Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06729775 · ClinicalTrials.gov registry record · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
A NA study of Education, Health, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 1,546
- Enrollment target
- 1
- Study location
NCT06729775: Recruiting NA study of Education, Health, sponsored by University of Arizona.
NCT06729775 is a NA study of Education, Health that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 1,546 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06729775, a NA study of Education, Health, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,546 participants
- Enrollment target
- 1
- Study location
Study Summary
There remains a need for novel research that facilitates RBRR in a manner that raises data and environmental health literacy (D/EHL) and supports communities striving for environmental health and structural change. Rooted in bioethics and building upon trusted and established long-term partnerships and leveraging existing datasets, the project goal is to create and pilot a national model of report back that is centered in the margins and engages diverse rural and urban EJ communities to ensure that RBRR reaches all populations in a manner tailored to their individual needs, including culture, life stage, language, and design.
Primary Outcome
Likert scale where one is equivalent to "Disagree Very Strongly" and six is Agree Very Strongly.
Conditions Studied
Interventions
- OTHER Data report back preference by life span
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,546 participants |
| Start Date | 2025-02-21 |
| Est. Completion | 2028-05 |
| Phase | NA |
What NCT06729775 shows while recruiting
NCT06729775 is an interventional study that assigns participants to a tested intervention. Its 1,546 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% higher).
The record links to 1 condition, with Education, Health appearing as the primary indexed condition, and to 1 intervention - of which Data report back preference by life span is the first listed.
NCT06729775 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06729775 about?
NCT06729775 is a clinical study titled "Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back". There remains a need for novel research that facilitates RBRR in a manner that raises data and environmental health literacy (D/EHL) and supports communities striving for environmental health and structural change. Rooted in bioethics and building upon trusted and established long-term partnerships ...
What is the current status of trial NCT06729775?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,546 participants. The study started on 2025-02-21. Estimated completion is 2028-05.
What conditions does trial NCT06729775 study?
This clinical trial studies the following conditions: Education, Health.
What interventions are being tested in trial NCT06729775?
The interventions under investigation include: Data report back preference by life span (OTHER).
Who is sponsoring clinical trial NCT06729775?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06729775 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06729775's enrollment target sits among peer trials
1,546 65th of 2000 higher than 1,936 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- NCT06842875 · 1,536 participants · NA
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI